Viewing Study NCT00089856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-10 @ 1:38 PM
Study NCT ID: NCT00089856
Status: TERMINATED
Last Update Posted: 2008-11-05
First Post: 2004-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor: Cell Genesys
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate View
None Cancer View
None Metastatic View
None Hormone-refractory View
None GVAX View
None Chemotherapy View
None Taxotere View
None Docetaxel View
None Prednisone View
None Vaccine View
None Allogeneic cells View
None Advanced Prostate Cancer View